User profiles for Jakob de Vries

Jakob de Vries MD PhD

Associate professor UMCG
Verified email at umcg.nl
Cited by 4029

[HTML][HTML] Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions

…, M Graafland, J de Vries, J Bart, JS de Jong… - Annals of surgical …, 2009 - Springer
Inadequate surgical margins represent a high risk for adverse clinical outcome in breast-conserving
therapy (BCT) for early-stage breast cancer. The majority of studies report positive …

[HTML][HTML] Extra-intestinal manifestations of familial adenomatous polyposis

…, A Roos, FL Muntinghe, RH Enting, J de Vries… - Annals of surgical …, 2008 - Springer
Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disorder, which
results from a germ line mutation in the APC (adenomatous polyposis coli) gene. FAP is …

Evolution in sentinel lymph node biopsy in breast cancer

…, J de Vries, CP Schröder, EGE de Vries… - Critical reviews in …, 2018 - Elsevier
… Author links open overlay panel Si-Qi Qiu a b c , Guo-Jun Zhang c d , Liesbeth Jansen b ,
Jakob de Vries b , Carolien P. Schröder a , Elisabeth GE de Vries a , Gooitzen M. van Dam b e …

Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis.

…, VS Helgeson, H Seltman, J de Vries… - Health …, 2010 - psycnet.apa.org
Objective: In this article, we aim to (a) identify distinct trajectories of psychological distress in
the first year after a breast cancer diagnosis in women treated with adjuvant therapy and (b) …

Tumor-specific uptake of fluorescent bevacizumab–IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study

…, L Jansen, J de Vries, MN Lub-de Hooge… - Clinical Cancer …, 2017 - AACR
Purpose: To provide proof of principle of safety, breast tumor–specific uptake, and positive
tumor margin assessment of the systemically administered near-infrared fluorescent tracer …

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age

…, M Schaapveld, MJE Mourits, J de Vries… - Breast cancer research …, 2010 - Springer
Accurate estimations of lifetime risks of breast and ovarian cancer are crucial for counselling
women from BRCA1/2 families. We therefore determined breast and ovarian cancer …

89Zr-bevacizumab PET imaging in primary breast cancer

…, J de Vries, L Jansen, EGE de Vries… - Journal of nuclear …, 2013 - Soc Nuclear Med
Vascular endothelial growth factor (VEGF)-A is overexpressed in most malignant and
premalignant breast lesions. VEGF-A can be visualized noninvasively with PET imaging and using …

[HTML][HTML] Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

…, HSA Oldenburg, K van Engelen, J de Vries… - Breast cancer research …, 2019 - Springer
Background In healthy BRCA1/2 mutation carriers, bilateral risk-reducing mastectomy (BRRM)
strongly reduces the risk of developing breast cancer (BC); however, no clear survival …

[HTML][HTML] Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

…, MD Linssen, L Jansen, W Kelder, J de Vries… - Nature …, 2018 - nature.com
During the last decade, the emerging field of molecular fluorescence imaging has led to the
development of tumor-specific fluorescent tracers and an increase in early-phase clinical …

[HTML][HTML] A longitudinal comparison of arm morbidity in stage I–II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed …

…, JS Rietman, J de Vries… - Annals of surgical …, 2010 - Springer
Background Long-term shoulder and arm function following sentinel lymph node biopsy (SLNB)
may surpass that following complete axillary lymph node dissection (CLND) or axillary …